China Universal Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$1.17 Billion
Q3 2025

A detailed history of China Universal Asset Management Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 42,234 shares of ARWR stock, worth $1.74 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

42,234

Previous 27,737 52.27%

Holding current value

$1.74 Million

Previous $438,000 232.42%

% of portfolio

0.12%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$14.71 - $34.49 $213,250 - $500,001	14,497 Added 52.27%	42,234 $1.46 Million
Q2 2025 Aug 28, 2025	BUY	$9.99 - $16.97 $24,415 - $41,474	2,444 Added 9.66%	27,737 $438,000
Q1 2025 Apr 29, 2025	SELL	$12.74 - $21.53 $13,912 - $23,510	-1,092 Reduced 4.14%	25,293 $322,000
Q4 2024 Jan 23, 2025	BUY	$17.7 - $26.34 $43,807 - $65,191	2,475 Added 10.35%	26,385 $496,000
Q3 2024 Oct 25, 2024	BUY	$19.36 - $29.54 $180,396 - $275,253	9,318 Added 63.86%	23,910 $462,000
Q2 2024 Jul 19, 2024	SELL	$21.87 - $28.24 $202,210 - $261,107	-9,246 Reduced 38.79%	14,592 $379,000
Q1 2024 Apr 29, 2024	BUY	$27.21 - $39.48 $310,438 - $450,427	11,409 Added 91.79%	23,838 $682,000
Q4 2023 May 21, 2024	SELL	$21.2 - $31.03 $241,870 - $354,021	-11,409 Reduced 47.86%	12,429 $380,000
Q4 2023 Jan 23, 2024	BUY	$21.2 - $31.03 $205,131 - $300,246	9,676 Added 351.47%	12,429 $380,000
Q3 2023 May 21, 2024	BUY	$26.2 - $36.08 $35,422 - $48,780	1,352 Added 96.5%	2,753 $73,000
Q3 2023 Oct 30, 2023	BUY	$26.2 - $36.08 $35,422 - $48,780	1,352 Added 96.5%	2,753 $74,000
Q2 2023 May 21, 2024	SELL	$25.16 - $41.38 $1,660 - $2,731	-66 Reduced 4.5%	1,401 $49,000
Q2 2023 Jul 27, 2023	SELL	$25.16 - $41.38 $1,660 - $2,731	-66 Reduced 4.5%	1,401 $50,000
Q1 2023 May 21, 2024	BUY	$23.68 - $38.51 $9,235 - $15,018	390 Added 36.21%	1,467 $37,000
Q1 2023 Apr 27, 2023	BUY	$23.68 - $38.51 $9,235 - $15,018	390 Added 36.21%	1,467 $37,000
Q4 2022 May 21, 2024	SELL	$28.0 - $40.56 $637,308 - $923,186	-22,761 Reduced 95.48%	1,077 $43,000
Q4 2022 Jan 31, 2023	BUY	$28.0 - $40.56 $2,380 - $3,447	85 Added 8.57%	1,077 $44,000
Q3 2022 Oct 21, 2022	BUY	$29.63 - $48.31 $29,392 - $47,923	992 New	992 $33,000

Others Institutions Holding ARWR

# of Institutions

339

Shares Held

103M

Call Options Held

953K

Put Options Held

263K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History